Peter Rahmer, See remarks at Relay Therapeutics, Inc. (RLAY), sold 13,038 shares at $7.62 ($100K) on 2026-01-27, disclosed to the SEC on 2026-01-29.
Seasonal sale ($100k) by See remarks — this insider has traded RLAY in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.62 | 11,684 | $89K | 88.6% |
| 2 | $8.45 | 1,354 | $11K | 11.4% |
| Total | $7.71 avg | 13,038 | $100K | 100% |
| Filing → |
| RLAY | SELL | 2026-07-02 | $955K | — | Filing → |
| RLAY | SELL | 2026-04-30 | $11K | — | Filing → |
| RLAY | SELL | 2025-10-30 | $439K | — | Filing → |